Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Change in Acquisitions & Divestments (2021 - 2024)

Historic Change in Acquisitions & Divestments for Orthopediatrics (KIDS) over the last 4 years, with Q2 2024 value amounting to $26.4 million.

  • Orthopediatrics' Change in Acquisitions & Divestments fell 2483.4% to $26.4 million in Q2 2024 from the same period last year, while for Mar 2025 it was $26.4 million, marking a year-over-year decrease of 7338.69%. This contributed to the annual value of $49.9 million for FY2024, which is 5584.3% down from last year.
  • Latest data reveals that Orthopediatrics reported Change in Acquisitions & Divestments of $26.4 million as of Q2 2024, which was down 2483.4% from $23.5 million recorded in Q1 2024.
  • Over the past 5 years, Orthopediatrics' Change in Acquisitions & Divestments peaked at $37.2 million during Q1 2023, and registered a low of $1.3 million during Q4 2022.
  • Over the past 4 years, Orthopediatrics' median Change in Acquisitions & Divestments value was $17.6 million (recorded in 2022), while the average stood at $18.2 million.
  • Per our database at Business Quant, Orthopediatrics' Change in Acquisitions & Divestments crashed by 7441.9% in 2022 and then surged by 167691.73% in 2023.
  • Over the past 4 years, Orthopediatrics' Change in Acquisitions & Divestments (Quarter) stood at $5.2 million in 2021, then tumbled by 74.42% to $1.3 million in 2022, then soared by 1676.92% to $23.9 million in 2023, then increased by 10.55% to $26.4 million in 2024.
  • Its Change in Acquisitions & Divestments was $26.4 million in Q2 2024, compared to $23.5 million in Q1 2024 and $23.9 million in Q4 2023.